Walgreens Boots Alliance (BUE:WBA) Long-Term Debt: ARS8,210,728.70 Mil (As of May. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Walgreens Boots Alliance Long-Term Debt?

Walgreens Boots Alliance BUE:WBA 15 Long-Term Debt is ARS8,210,728.70 Mil as of May. 2025. GuruFocus rates BUE:WBA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Walgreens Boots Alliance's Long-Term Debt for the quarter that ended in May. 2025 was ARS8,210,728.70 Mil.

Walgreens Boots Alliance's quarterly Long-Term Debt declined from Nov. 2024 (ARS7,534,890.08 Mil) to Feb. 2025 (ARS7,018,584.22 Mil) but then increased from Feb. 2025 (ARS7,018,584.22 Mil) to May. 2025 (ARS8,210,728.70 Mil).

Walgreens Boots Alliance's annual Long-Term Debt increased from Aug. 2022 (ARS1,400,144.24 Mil) to Aug. 2023 (ARS2,248,020.00 Mil) and increased from Aug. 2023 (ARS2,248,020.00 Mil) to Aug. 2024 (ARS7,497,007.81 Mil).

Walgreens Boots Alliance  (BUE:WBA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Walgreens Boots Alliance Long-Term Debt Related Terms

Walgreens Boots Alliance Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Walgreens Boots Alliance's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance Long-Term Debt Chart

Walgreens Boots Alliance Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 882,398.90 555,051.54 1,400,144.24 2,248,020.00 7,497,007.81

Walgreens Boots Alliance Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,492,235.57 7,497,007.81 7,534,890.08 7,018,584.22 8,210,728.70
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ARS8,210,728.70 Mil mean?
Walgreens Boots Alliance (BUE:WBA) has a Long-Term Debt of ARS8,210,728.70 Mil as of May. 2025.
Is Walgreens Boots Alliance's Long-Term Debt too high?
Walgreens Boots Alliance's current Long-Term Debt is ARS8,210,728.70 Mil. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's Long-Term Debt compare to WGRX and PETS?
Walgreens Boots Alliance's Long-Term Debt of ARS8,210,728.70 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Walgreens Boots Alliance's current Long-Term Debt is ARS8,210,728.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current Long-Term Debt of ARS8,210,728.70 Mil. The current Long-Term Debt is ARS8,210,728.70 Mil. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current Long-Term Debt is ARS8,210,728.70 Mil as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walgreens Boots Alliance Business Description

Address 108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.